Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News and analysis

New rapid HIV test opens Pandora‚s box of ethical concerns

Barbara Sibbald
CMAJ May 30, 2000 162 (11) 1600;
Barbara Sibbald
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

A new HIV test that provides results in just 15 minutes is undoubtedly more convenient and faster, but observers say it also raises concerns about appropriate counselling, administration of the test and ways to deal with false-positive results (see pages 1545, 1605).

The Canadian HIV-AIDS Legal Network has responded to the new product with a 145-page report that urges provincial and territorial governments and regulatory bodies to run pilot studies on the new tests before mass marketing takes place. The studies would assess the need for counselling, training and quality control.

The test, which was approved by Health Canada in mid-March, is the country‚s first rapid screening test and the only HIV test possible outside a laboratory. It is considered as accurate as the current standard, the ELISA laboratory test, but results from that take 2 weeks.

The report‚s coauthor, lawyer Richard Elliott, says the Legal Network‚s major concern is the quality of counselling, especially given the number of false-positive results. This figure varies according to the HIV seroprevalence within a population, but it can be quite high. For example, 300 000 ELISA tests were conducted in Ontario last year, and 3000 were positive. After a second confirmatory test, only 1000 of the people tested were found to be HIV positive. (Patients are not notified of their status until after the second test.)

With rapid testing, however, patients would be informed of their status on the spot, before any confirmatory test had taken place. ”It‚s crucial in counselling that they understand they may or may not be positive,” says Elliott, director of policy and research at the Legal Network, a nonprofit group that takes the lead in analysing legal and ethical issues raised by HIV testing. It is urging regulatory bodies, provinces and territories to establish practice guidelines regarding who can provide rapid testing and to ensure training and counselling specific to the new test.

Elliott says the ease of rapid testing will increase the likelihood of poor counselling and lack of proper consent. ”We‚re concerned that people will feel pressure to have this test done without adequately considering the ramifications of a positive result,” he says.

”Pre-test counselling is the standard of care that must be met in any HIV testing,” concurs Dr. Phil Berger, the chief of family and community medicine at Toronto‚s St. Michael‚s Hospital. ”My worry is that [counselling] won‚t occur if testing is being done by a range of professionals who aren‚t necessarily trained in counselling.”

The Health Canada licence stipulates that the test, which is marketed by BioChem ImmunoSystems Inc. of Montreal, can only be used by health care professionals at the point of care. However, each province and territory has its own definition of ”health care professional,” and in some cases it includes dentists and registered massage therapists. Many of these professionals are not currently trained to provide counselling, says Elliott.

There is also some concern that the test could make its way to the black market and be used for unscrupulous purposes by employers. Elliott argues that these people should be prosecuted. ”I don‚t want to see circumstances where someone takes this kit and forces a spouse or child or employee to take it,” he says. ”It raises concerns about informed consent.” US regulators have already approved home test kits for HIV that cost about US$40.

PreviousNext
Back to top

In this issue

CMAJ
Vol. 162, Issue 11
30 May 2000
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
New rapid HIV test opens Pandora‚s box of ethical concerns
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
New rapid HIV test opens Pandora‚s box of ethical concerns
Barbara Sibbald
CMAJ May 2000, 162 (11) 1600;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
New rapid HIV test opens Pandora‚s box of ethical concerns
Barbara Sibbald
CMAJ May 2000, 162 (11) 1600;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A step toward putting a genie back in its bottle
  • Google Scholar

More in this TOC Section

  • More medical students for Dalhousie
  • Stressed parents at “loggerheads” with children, report says
  • Number of medical school applicants drops on both sides of border
Show more News and Analysis

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire